Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in barrett's dysplasia

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 9, 2010, Pages

  Wani, Sachin ^a   Mathur, Sharad C ^a   Curvers, Wouter L ^b   Singh, Vikas ^a   Herrero, Lorenza Alvarez ^b   Hall, Sandy B ^a   Ulusarac, Ozlem ^a   Cherian, Rachel ^a   McGregor, Douglas H ^a   Bansal, Ajay ^a   Rastogi, Amit ^a   Ahmed, Basem ^a   Singh, Mandeep ^a   Gaddam, Srinivas ^a   Ten Kate, Fiebo J ^b   Bergman, Jacques ^b   Sharma, Prateek ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Barrett's Esophagus; Dysplasia; Endoscopic Mucosal Resection; Esophageal Adenocarcinoma

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; ENDOSCOPIC MUCOSAL RESECTION; EPITHELIUM; ESOPHAGUS BIOPSY; GASTROINTESTINAL DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LAMINA PROPRIA; MAJOR CLINICAL STUDY; STOMACH MUSCLE; SUBMUCOSA;

EID: 77956172301     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.04.028     Document Type: Article

References (31)

1. Sharma P., McQuaid K., Dent J., et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004, 127:310-330.
2. Pohl H., Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005, 97:142-146.
3. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
4. Odze R.D. Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol 2006, 59:1029-1038.
5. Rastogi A., Puli S., El-Serag H.B., et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 2008, 67:394-398.
6. Montgomery E., Bronner M.P., Goldblum J.R., et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001, 32:368-378.
7. Reid B.J., Haggitt R.C., Rubin C.E., et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988, 19:166-178.
8. Downs-Kelly E., Mendelin J.E., Bennett A.E., et al. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol 2008, 103:2333-2340. quiz 2341.
9. Peters F.P., Brakenhoff K.P., Curvers W.L., et al. Endoscopic cap resection for treatment of early Barrett's neoplasia is safe: a prospective analysis of acute and early complications in 216 procedures. Dis Esophagus 2007, 20:510-515.
10. Peters F.P., Kara M.A., Curvers W.L., et al. Multiband mucosectomy for endoscopic resection of Barrett's esophagus: feasibility study with matched historical controls. Eur J Gastroenterol Hepatol 2007, 19:311-315.
11. Wani S., Sayana H., Sharma P. Technical review: endoscopic eradication of Barrett's esophagus. Gastrointest Endosc 2010, 71:147-166.
12. Sayana H., Wani S., Keighley J.D., et al. Endoscopic mucosal resection (EMR) as a diagnostic tool in Barrett's esophagus (BE) patients with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC): a systematic review. Gastroenterology 2008, 134:A-724.
13. Mino-Kenudson M., Hull M.J., Brown I., et al. EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc 2007, 66:660-666. quiz 767, 769.
14. Schlemper R., Riddell R.H., Kato Y., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47:251-255.
15. Schlemper R., Kato Y., Stolte M. Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gastroenterol Hepatol 2000, 15(Suppl):G49-G57.
16. Landis J., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
17. Donner A. Sample size requirements for the comparison of two or more coefficients of inter-observer agreement. Stat Med 1998, 17:1157-1168.
18. Westerterp M., Koppert L.B., Buskens C.J., et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005, 446:497-504.
19. Wang K.K., Sampliner R.E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008, 103:788-797.
20. Pech O., Behrens A., May A., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008, 57:1200-1206.
21. Waxman I., Raju G.S., Critchlow J., et al. High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series. Am J Gastroenterol 2006, 101:1773-1779.
22. May A., Gunter E., Roth F., et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004, 53:634-640.
23. Hull M.J., Mino-Kenudson M., Nishioka N.S., et al. Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am J Surg Pathol 2006, 30:114-118.
24. Prasad G.A., Buttar N.S., Wongkeesong L.M., et al. Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus. Am J Gastroenterol 2007, 102:2380-2386.
25. Buskens C.J., Westerterp M., Lagarde S.M., et al. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc 2004, 60:703-710.
26. Kelly S., Harris K.M., Berry E., et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 2001, 49:534-539.
27. Zuccaro G., Rice T.W., Vargo J.J., et al. Endoscopic ultrasound errors in esophageal cancer. Am J Gastroenterol 2005, 100:601-606.
28. Wani S., Mathur S., Sharma P. How to manage a Barrett's esophagus patient with low-grade dysplasia. Clin Gastroenterol Hepatol 2009, 7:27-32.
29. Wani S., Falk G.W., Sampliner R.E., et al. Low-grade dysplasia is a poor marker for cancer progression in patients with Barrett's esophagus: preliminary results from a large, multi-center, cohort study. Gastroenterology 2009, 136:A-592.
30. Scheil-Bertram S., Lorenz D., Ell C., et al. Expression of alpha-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus. Mod Pathol 2008, 21:961-967.
31. Peters F.P., Brakenhoff K.P., Curvers W.L., et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus. Gastrointest Endosc 2008, 67:604-609.